The Enteric Softgel Capsules Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for enteric softgel capsules has experienced robust growth in previous years. The market is projected to rise from $2.34 billion in 2024 to $2.46 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.23%.
The Enteric Softgel Capsules Global Market is projected to reach a market size of $2.99 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.97%.
Download Your Free Sample of the 2025 Enteric Softgel Capsules Market Report and Uncover Key Trends Now!The key drivers in the enteric softgel capsules market are:
•Greater focus on clinical trials
•Increasing dependence on online platforms
•Higher emphasis on preventive healthcare
•Rise in incidents of nutritional disorders
The enteric softgel capsules market covered in this report is segmented –
1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules
2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores
3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications
4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry
Subsegments:
1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules
2) By Non-Gelatin Softgel Capsules: Plant-based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules
The key trends in the enteric softgel capsules market are:
•Technological advancements are driving changes in the market.
•Clinical trials are expected to become even more central to the market.
•Innovation in manufacturing processes is a critical emerging trend.
•A growing emphasis on partnerships and product innovation are shaping the market.
Major players in the enteric softgel capsules market are:
• BASF SE
• Thermo Fisher Scientific Inc.
• United Laboratories International Inc.
• Herbalife Nutrition Ltd.
• Catalent Pharma Solutions Inc.
• Sirio Pharma Co. Ltd.
• NOW Health Group Inc.
• Patheon
• GELITA AG
• Colorcon Inc.
• Aenova Group GmbH
• ProCaps Laboratories Inc.
• CAPTEK Softgel International Inc.
• Renown Pharmaceuticals Private Limited
• Viva Pharmaceutical Inc.
• Biofield Pharma Private Limited
• CapsCanada Corporation
• Natural Capsules Limited
• Fuji Capsules Co. Ltd.
• Conch Lifescience Co. Ltd.
North America was the largest region in the enteric softgel capsules market in 2024